Genetic association studies of interleukin-13 receptor α1 subunit gene polymorphisms in asthma and atopy Source: Eur Respir J 2007; 30: 40-47 Year: 2007
Steroids induce a disequilibrium of secreted interleukin-1 receptor antagonist and interleukin-1? synthesis by human neutrophils Source: Eur Respir J 2011; 37: 406 Year: 2011
Homozygosity for the FCER2 gene is associated with an increased use of leukotriene receptor antagonists Source: International Congress 2017 – Insight into childhood asthma and paediatric pulmonology Year: 2017
Effects of the grippe vaccination, smoking cessation, and short acting beta agonist in COPD subjects Source: Annual Congress 2012 - Effectiveness of therapeutic interventions in primary care Year: 2012
Novel approach to prevention of dust-induced acute lung injury with interleukin-1 receptor antagonist (IL-1ra) Source: Eur Respir J 2003; 22: Suppl. 45, 459s Year: 2003
CHRNA3 genotype, nicotine dependence, lung function and disease in the general population Source: Eur Respir J 2012; 40: 1538-1544 Year: 2012
Association of genetic variations of CC chemokine receptor-2 (CCR2) with atopic asthma, but not with nonatopic asthma Source: Annual Congress 2005 - Genetic polymorphisms and molecular mechanisms in asthma pathophysiology Year: 2005
Interaction between the Arg16 homozygous genotype, inhaled corticosteroids and long acting beta agonists for asthma exacerbations in children? Leukotriene receptor antagonists to the rescue? Source: Annual Congress 2013 –Asthma and lung development: from genes to environment Year: 2013
Effect of leukotriene receptor antagonist on expression and variation of TGF-beta in T lymphocyte for mild persistent asthma in children Source: Annual Congress 2011 - Treating childhood asthma Year: 2011
Use of interleukin-1beta (IL-1beta) and interleukin-1 receptor antagonist (IL-1Ra) contents in alveolar macrophages for estimation of inflammation activity in patients with different levels of asthma control Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection Year: 2013
The treatment of bleomycin-induced lung injury with combination of antioxidants and interleukin-1 receptor antagonist (IL-1ra) Source: Eur Respir J 2002; 20: Suppl. 38, 488s Year: 2002
Susceptibility to chronic bacterial purulent rhinosinusitis is associated with the combination of interleukin-1 beta and interleukin-1 receptor antagonist gene polymorphic alleles Source: Eur Respir J 2005; 26: Suppl. 49, 406s Year: 2005
Prevention of oxidative stress in rats exposed to industrial dust with interleukin-1 receptor antagonist (IL-1ra) Source: Eur Respir J 2001; 18: Suppl. 33, 445s Year: 2001
Interleukin-1b and interleukin-1 receptor antagonist gene polymorphisms in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 136s Year: 2004
The relationship between interleukin-1 receptor antagonist polymorphism and tuberculosis disease Source: Annual Congress 2006 - Immunology of tuberculosis and diagnosis of tuberculosis infection Year: 2006
Use of anti-inflammatory therapy and asthma mortality in Japan Source: Eur Respir J 2003; 21: 101-104 Year: 2003
Increased expression of ADRB2, CHRM3 and glucocorticoid alpha receptor genes in blood leukocytes of COPD patients Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action Year: 2016
Efficacy of UR-63325, a new H4 receptor antagonist, in two rodent asthma models Source: Annual Congress 2010 - Models of airways disease Year: 2010
A comprehensive analysis of toll-like receptor 1-10 polymorphisms and their role in childhood asthma Source: Eur Respir J 2006; 28: Suppl. 50, 257s Year: 2006
Salmeterol response is not affected by beta2 -adrenergic receptor genotype in patients with persistent asthma Source: Eur Respir J 2005; 26: Suppl. 49, 505s Year: 2005